Decitabine and HQP1351-based Chemotherapy Regimen for the Treatment Advanced CML

Clinical trial NCT05376852 · UNKNOWN

Trial details

NCT number: NCT05376852
Sponsor: Nanfang Hospital, Southern Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia in Myeloid Blast Crisis Chronic Myeloid Leukaemia Transformation Chronic Myeloid Leukemia - Accelerated Phase Chronic Myeloid Leukemia in Lymphoid Blast Crisis

Start date: 2021-12-01
Primary completion: 2024-12-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.